China
· Delayed Price · Currency is CNY Shenyang Xingqi Pharmaceutical Co.,Ltd. Statistics
Total Valuation
Shenyang Xingqi Pharmaceutical Co.,Ltd. has a market cap or net worth of CNY 15.34 billion. The enterprise value is 15.08 billion.
| Market Cap | 15.34B |
| Enterprise Value | 15.08B |
Important Dates
The last earnings date was Thursday, October 24, 2024.
| Earnings Date | Oct 24, 2024 |
| Ex-Dividend Date | Oct 16, 2024 |
Share Statistics
Shenyang Xingqi Pharmaceutical Co.,Ltd. has 175.25 million shares outstanding. The number of shares has increased by 1.04% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 175.25M |
| Shares Change (YoY) | +1.04% |
| Shares Change (QoQ) | -1.23% |
| Owned by Insiders (%) | 30.76% |
| Owned by Institutions (%) | 21.04% |
| Float | 121.33M |
Valuation Ratios
The trailing PE ratio is 43.81 and the forward PE ratio is 34.03.
| PE Ratio | 43.81 |
| Forward PE | 34.03 |
| PS Ratio | 8.47 |
| PB Ratio | 9.38 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 56.86 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 31.09, with an EV/FCF ratio of 55.91.
| EV / Earnings | 43.28 |
| EV / Sales | 8.37 |
| EV / EBITDA | 31.09 |
| EV / EBIT | 38.68 |
| EV / FCF | 55.91 |
Financial Position
The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.96 |
| Quick Ratio | 1.59 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 0.51 |
| Debt / FCF | 0.92 |
| Interest Coverage | 83.14 |
Financial Efficiency
Return on equity (ROE) is 21.63% and return on invested capital (ROIC) is 13.80%.
| Return on Equity (ROE) | 21.63% |
| Return on Assets (ROA) | 11.87% |
| Return on Capital (ROIC) | 13.80% |
| Revenue Per Employee | 903,258 |
| Profits Per Employee | 174,670 |
| Employee Count | 1,995 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 3.00 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.12% in the last 52 weeks. The beta is 0.07, so Shenyang Xingqi Pharmaceutical Co.,Ltd.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.07 |
| 52-Week Price Change | -13.12% |
| 50-Day Moving Average | 87.28 |
| 200-Day Moving Average | 131.66 |
| Relative Strength Index (RSI) | 44.86 |
| Average Volume (20 Days) | 10,497,704 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shenyang Xingqi Pharmaceutical Co.,Ltd. had revenue of CNY 1.80 billion and earned 348.47 million in profits. Earnings per share was 2.00.
| Revenue | 1.80B |
| Gross Profit | 1.40B |
| Operating Income | 389.84M |
| Pretax Income | 400.16M |
| Net Income | 348.47M |
| EBITDA | 476.54M |
| EBIT | 389.84M |
| Earnings Per Share (EPS) | 2.00 |
Balance Sheet
The company has 503.31 million in cash and 247.29 million in debt, giving a net cash position of 256.02 million or 1.46 per share.
| Cash & Cash Equivalents | 503.31M |
| Total Debt | 247.29M |
| Net Cash | 256.02M |
| Net Cash Per Share | 1.46 |
| Equity (Book Value) | 1.63B |
| Book Value Per Share | 9.33 |
| Working Capital | 464.41M |
Cash Flow
In the last 12 months, operating cash flow was 447.30 million and capital expenditures -177.60 million, giving a free cash flow of 269.70 million.
| Operating Cash Flow | 447.30M |
| Capital Expenditures | -177.60M |
| Free Cash Flow | 269.70M |
| FCF Per Share | 1.54 |
Margins
Gross margin is 77.59%, with operating and profit margins of 21.63% and 19.34%.
| Gross Margin | 77.59% |
| Operating Margin | 21.63% |
| Pretax Margin | 22.21% |
| Profit Margin | 19.34% |
| EBITDA Margin | 26.45% |
| EBIT Margin | 21.63% |
| FCF Margin | 14.97% |
Dividends & Yields
This stock pays an annual dividend of 2.03, which amounts to a dividend yield of 2.24%.
| Dividend Per Share | 2.03 |
| Dividend Yield | 2.24% |
| Dividend Growth (YoY) | 185.83% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 108.56% |
| Buyback Yield | -1.04% |
| Shareholder Yield | 1.20% |
| Earnings Yield | 2.28% |
| FCF Yield | 1.76% |
Stock Splits
The last stock split was on May 22, 2024. It was a forward split with a ratio of 1.4.
| Last Split Date | May 22, 2024 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
Shenyang Xingqi Pharmaceutical Co.,Ltd. has an Altman Z-Score of 26.76.
| Altman Z-Score | 26.76 |
| Piotroski F-Score | n/a |